Skip to content

Repetitive Transcranial Magnetic Stimulation for the Treatment of Freezing of Gait in Parkinson's Disease

Repetitive Transcranial Magnetic Stimulation for the Treatment of Freezing of Gait in Parkinson's Disease: A Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04431570
Enrollment
66
Registered
2020-06-16
Start date
2020-06-15
Completion date
2022-06-14
Last updated
2020-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gait Disorders, Neurologic, Parkinson Disease

Keywords

freezing of gait, FMRI, rTMS

Brief summary

Freezing of gait (FOG) is a common and devastating symptom in advanced stage Parkinson's disease (PD), which contributes to falls and disability. Unfortunately, there is no effective pharmacological treatment for FOG. It is suggested that the cortex-basal ganglia circuit, especially the frontal lobe, plays an important role in the pathogenesis of FOG. Repetitive transcranial magnetic stimulation (rTMS) effects over the cortex and affects the subcortical neural circuits. Previous studies have demonstrated that rTMS can improve FOG for PD patients. In the present randomized controlled trial (RCT) study, the invastigators aim to investigate the efficiency of rTMS over different motor regions of frontal lobe. The efficacy of treatment is evaluated by the score of FOG questionnaire and FOG provoking test, and the changing of neural network shown by functional magnetic resonance imaging (FMRI). Then the effects of rTMS over different brain regions will be compared for choosing a better target. The study will provide the evidence for non-invasive neuro-modulation of Parkinson's disease with freezing of gait (PD-FOG).

Interventions

DEVICErTMS

The device is made in London, United Kingdom

DEVICEsham stimulation

the device of sham stimulation was MagStim MC-P-B70 placebo butterfly coil

Sponsors

Peking Union Medical College Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
50 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Subjects fulfilled the diagnosis of idiopathic Parkinson's disease according to MDS-PD criteria * Hoehn & Yahr (H-Y) stage was 2 or 3 * All subjects had freezing of gait which was identified by FOGQ

Exclusion criteria

* cognitive impairment (MMSE score\<22) or major depression (HAMD-24 score\>25) * severe visual and/or haring impairment * significant medical or psychiatric illnesses * history of deep brain stimulation (DBS) surgery or pacemaker implantation. MRI cannot be performed in those patients * current treatment with medication cannot be maintained during the study

Design outcomes

Primary

MeasureTime frameDescription
the change of freezing of gait questionnaire (FOGQ)through study completion, an average of 2 weeksa self-assessment scale for evaluating FOG severity,the minimum value is 0, the maximum value is 24, and higher scores mean a worse outcome.

Secondary

MeasureTime frameDescription
the change of score of Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) part IIIthrough study completion, an average of 2 weeksassess the motor ability, the minimum value is 0, the maximum value is 132, and higher scores mean a worse outcome.
the change of Hamilton Depression (HAMD) Scalethrough study completion, an average of 2 weeksassess the severity of depression, the minimum value is 0, the maximum value is 76, and higher scores mean a worse outcome.
the change of freezing of gait score (FOG score)through study completion, an average of 2 weeksassess the severity of FOG, the minimum value is 0, the maximum value is 36, and higher scores mean a worse outcome.
the change of Parkinson's Disease Questionnaire (PDQ-39)through study completion, an average of 2 weeksassess the quality of life, the minimum value is 0, the maximum value is 156, and higher scores mean a worse outcome.
functional image of the brain (FMRI)through study completion, an average of 10 daysgraph theoretical analysis of the brain network
the change of Mini-mental State Examination (MMSE) scalethrough study completion, an average of 2 weeksassess the severity of mental state, the minimum value is 0, the maximum value is 30, and higher scores mean a worse outcome.

Countries

China

Contacts

Primary ContactHan Wang, doctor
18600044179@163.com+8618600044179
Backup ContactDan Xu, doctor
pumc04xd@163.com+8618614069673

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026